SUBSCRIBE
SUBSCRIBE
News   Business

Astellas Pharma Inc. (JOBS) Scraps Agreement with Neurosearch A/S on ACR16

March 4, 2009 | 
1 min read
TOKYO, March 3 (Reuters) - Astellas Pharma Inc, Japan's second-biggest drugmaker, said on Tuesday that it has scrapped its licensing agreement with a Neurosearch A/S unit on a drug to treat schizophrenia.
Alliances Asia
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Digital collage modern art. Hands reaching together and shaking, with loading icon
Mergers & acquisitions
Regeneron Backs Off 23andMe, Losing Bid to Former CEO
June 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Contemporary art collage. Human hand taking off book symbolizing growth of professional skills and knowledges. Education. Concept of business, office, career, creativity, growth, achievement, ad
Mergers & acquisitions
Sage’s Story Comes to ‘Good End’ With Up To $795M Acquisition by Supernus
June 16, 2025
 · 
2 min read
 · 
Annalee Armstrong
Facade of AstraZeneca's office in Shanghai, China
Artificial intelligence
AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills
June 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Big fish eats small, takeover of the company. Art collage.
Mergers & acquisitions
BioNTech Swallows Vaccine Rival CureVac in $1.25B All-Stock Acquisition
June 12, 2025
 · 
3 min read
 · 
Tristan Manalac